Thromb Haemost 1980; 44(03): 115-118
DOI: 10.1055/s-0038-1650099
Original Article
Schattauer GmbH Stuttgart

Acquired von Willebrand’s Syndrome in the Course of Waldenström’s Disease

Claudine Mazurier
The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
,
Armelle Parquet-Gernez
The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
,
Jacques Descamps
The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
,
Francis Bauters
The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
,
Maurice Goudemand
The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 02. April 1980

Accepted 19. September 1980

Publikationsdatum:
26. Juli 2018 (online)

Preview

Summary

Acquired von Willebrand's syndrome with a regressive evolution is described in a 66 year old man with Waldenström's disease. An inhibitor electively directed against Ristocetin cofactor activity has been demonstrated, active in vitro after incubation at 37° C. Serum fractionation showed that the inhibitor was independant of the monoclonal IgM and subsequent purification that it was IgG in nature. The results permit its classification as an auto-antibody.